FATE THERAPEUTICS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.6 | $13.6 | $63.5 | $96.3 | $55.8 |
| Operating income | -$147.7 | -$210.3 | -$190.5 | -$308.4 | -$217.0 |
| Net income | -$136.3 | -$186.3 | -$160.9 | -$281.7 | -$212.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$112.0 | -$123.6 | -$138.4 | -$283.8 | -$213.6 |
Shares outstanding 116.6M · Free float 81.1%
Annual filing data through FY ended December 31, 2025; float as of August 29, 2026.